| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ambrx Biopharma Inc. | Director | Ordinary Shares | 70.8K | $756K | $10.67 | Sep 1, 2023 | Direct |
| ONCOSEC MEDICAL Inc | Director | Common Stock | 20K | $27.4K | $1.37 | Aug 23, 2021 | Direct |
| Skye Bioscience, Inc. | Director | Stock Option (Right to Buy) | 35K | $595 | $0.02 | Feb 29, 2024 | Direct |
| Ambrx Biopharma, Inc. | Director | Restricted Stock Units | 0 | $0 | $9.82 | Mar 7, 2024 | Direct |
| ONCOSEC MEDICAL Inc | Director | Stock Option (Right to Buy) | 37.5K | Jun 28, 2021 | Direct | ||
| SEELOS THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 1.67K | Jan 4, 2024 | Direct |